Duncan Barbara Gayle 4
4 · Atea Pharmaceuticals, Inc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Duncan Barbara Gayle
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-16+33,150→ 33,150 total - Exercise/Conversion
Restricted Stock Units
2024-06-16−33,150→ 0 total→ Common Stock (33,150 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The restricted stock units are fully vested.
- [F3]The restricted stock units do not have an expiration date.